参考文献/References:
[1] Rui LY.Energy metabolism in the liver[J].Compr Physiol,2014,4(1):177-197.
[2] Bastien M,Poirier P,Lemieux I, et al.Overview of epidemiology and contribution of obesity to cardiovascular disease[J].Prog Cardiovasc Dis,2014,56(4):369-381.
[3] Toledo K,Aranda M,Asenjo S, et al.Unsaturated fatty acids and insulin resistance in childhood obesity[J].J Pediatr Endocrinol Metab,2014,27(5-6):503-510.
[4] Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance[J].J Clin Invest,2000,106(2):165-169.
[5] Hirasawa A, Hara T, Katsuma S. Free fatty acid receptors and drug discovery[J].Biol Pharm Bull,2008,31(10):1847-1851.
[6] Yi P,Lu F E,Xu LJ, et al.Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKKbeta[J].World J Gastroenterol,2008,14(6):876-883.
[7] Goodyear LJ, Giorgino F, Sherman LA, et al.Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects[J].J Clin Invest,1995,95(5):2195-2204.
[8] 洪靖, 李光伟. IRS-1基因与肥胖、 2型糖尿病[J]. 中日友好医院学报, 2003,17(2):107-109.
[9] White MF, Kahn CR. The insulin signaling system[J].J Biol Chem,1994,269(1):1-4.
[10] Gao Z,Zhang X,Zuberi A, et al.Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes[J].Mol Endocrinol,2004,18(8):2024-2034.